시장보고서
상품코드
1828846

세계의 DNA 백신 시장 분석 및 예측(-2034년) : 유형, 제품, 기술, 용도, 최종 사용자, 프로세스, 기능, 설치 유형, 솔루션별

DNA Vaccine Market Analysis and Forecast to 2034: Type, Product, Technology, Application, End User, Process, Functionality, Installation Type, Solutions

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 347 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 DNA 백신 시장은 2024년 8억 5,070만 달러에서 2034년까지 15억 7,460만 달러로 확대되어 CAGR 약 6.4%를 보일 것으로 예측됩니다. DNA 백신 시장은 질병에 대한 면역 반응을 일으키기 위해 인공 DNA를 사용하는 백신을 포함합니다. 이 백신은 특히 신흥 감염과 암에 안정성, 제조 용이성, 신속한 개발 가능성을 제공합니다. 이 시장을 견인하고 있는 것은 기술적 진보, R&D 투자 증가, 참신한 백신 솔루션에 대한 요구입니다. 규제 당국의 지원과 전략적 제휴가 시장 성장을 더욱 가속화하고 DNA 백신을 예방 의료의 변화의 힘으로 자리 매김하고 있습니다.

DNA 백신 시장은 유전 공학과 면역학의 진보에 힘입어 빠르게 확대되고 있습니다. 인간용 백신 분야는 감염증과 암의 유병률 증가에 견인되어 업적을 견인하고 있습니다. 이 중 치료용 백신 분야는 특히 암에의 응용이 기대되고 있습니다. 동물용 백신 분야는 인수 공통 감염에 대한 우려가 높아짐에 따라 가축용 백신이 견인역이 되어 2번째로 높은 실적을 올리고 있습니다. 수산 양식을 위한 DNA 백신은 또한 지속가능한 양식의 필요성에 대응하고 유리한 기회를 제공합니다. DNA 백신의 보급은 견고한 면역 반응을 유도하는 능력과 신속한 개발의 가능성으로 더욱 가속화되고 있습니다. 전기천공 및 나노입자 전달 시스템과 같은 기술 혁신은 백신의 효능과 환자의 컴플라이언스를 향상시킵니다. 생명 공학 기업과 연구 기관의 전략적 제휴 및 공동 연구는 제품 개발을 가속화하고 있습니다. 규제 당국의 지원과 정부의 호의적인 정책을 통해 DNA 백신은 현대 의료를 변화시키는 힘으로 자리매김하고 시장 성장이 지속될 것으로 기대되고 있습니다.

시장 세분화
유형 예방용 DNA 백신, 치료용 DNA 백신
제품 박테리아 DNA 백신, 바이러스 DNA 백신, 암 DNA 백신
기술 전기천공 전달, 유전자총 전달, 리포솜 전달, 나노입자 전달
용도 감염, 암, 알레르기 성 질환,자가 면역 질환
최종 사용자 병원, 조사 기관, 바이오 제약 회사
프로세스 In Vivo 생산, Ex Vivo 생산
기능성 유전자 발현, 항원 제시, 면역 반응 활성화
설치 유형 독립형 시스템, 통합형 시스템
솔루션 주문 DNA 백신 개발, 전임상시험 서비스, 임상시험 서비스

시장 현황

DNA 백신 시장은 시장 점유율, 가격 설정, 제품 혁신에서 역동적인 변화를 이루고 있습니다. 주요 기업은 효과적이고 안전한 백신에 대한 수요 증가에 대응하기 위해 지속적으로 신제품을 발표하고 있습니다. 경쟁 구도의 특징은 전략적 가격 모델과 다양한 소비자 요구에 부응하는 혁신적인 솔루션입니다. 이러한 진화는 생명공학의 진보와 DNA 백신의 잠재적인 이점에 대한 인식 증가에 의해 초래됩니다. 각 기업은 이러한 동향을 활용하여 큰 시장 점유율을 획득하고 있으며, 북미와 유럽이 제품의 출시와 기술 혁신으로 주도권을 잡고 있습니다. 경쟁 벤치마킹에 따르면, 주요 제약 회사를 필두로 하는 경쟁이 치열한 환경이 밝혀지고 있습니다. 특히 북미와 유럽에서 규제의 영향은 시장 역학을 형성하는 데 매우 중요합니다. 이러한 규정은 안전과 효능을 보장하며 시장 진입과 성장 전략에 영향을 미칩니다. 이 시장은 다양한 감염에 대한 백신 개발에 초점을 맞춘 활발한 R&D 활동을 특징으로 합니다. 아시아태평양과 라틴아메리카의 신흥 시장은 건강 관리 투자 증가와 정부의 호의적인 정책에 힘입어 큰 비즈니스 기회를 가져왔습니다.

주요 동향과 촉진요인:

DNA 백신 시장은 기술의 진보와 생명공학에 대한 투자 증가로 강력한 성장을 이루고 있습니다. 주요 동향은 감염의 유행이 증가하고 신속한 백신 개발이 시급하다는 것을 포함합니다. 이 때문에 기존 백신에 비해 보다 신속하고 적응성이 높은 대응이 가능한 DNA 백신의 연구 개발이 가속하고 있습니다. 규제 프레임워크는 DNA 백신의 독특한 특징을 수용할 수 있도록 진화하고 있으며 승인 프로세스가 원활하게 진행되고 있습니다. DNA 백신은 개인의 유전자 프로파일에 맞출 수 있기 때문에 맞춤형 의료 수요도 시장을 뒷받침하고 있습니다. 게다가, 동물의료에서 DNA 백신의 사용 증가도 시장의 곳곳을 넓히고 있습니다. 제약 회사와 연구 기관의 전략적 파트너십은 혁신을 촉진하고 DNA 백신 파이프라인을 강화하고 있습니다. 헬스케어 인프라가 정비되어 예방의료에 대한 관심이 높아지고 있는 신흥 시장에는 비즈니스 기회가 넘치고 있습니다. DNA 백신 시장은 이러한 매력적인 동향과 촉진요인에 힘입어 크게 확대되는 태세를 갖추고 있습니다.

억제요인과 도전:

DNA 백신 시장에는 몇 가지 심각한 억제요인과 도전이 있습니다. 엄격한 규제 요건은 광범위한 안전성과 효능 평가가 필요하고 시장 출시까지의 기간을 장기화하기 때문에 엄청난 장벽이 됩니다. 따라서 투자가 억제되고 기술 혁신이 지연될 수 있습니다. 게다가 바이오테크놀러지 분야의 연구개발은 비용이 많이 들기 때문에 자금력 있는 기업만 참가할 수 있어 경쟁과 다양성이 저해될 수 있습니다. 유전자 기술을 둘러싼 일반 대중의 회의심과 잘못된 정보는 시장 수용을 더욱 복잡하게 만듭니다. 많은 소비자들이 유전자 조작에 대해 우려하고 있으며, 이것이 보급의 방해가 되고 있습니다. 게다가, DNA 백신의 생산과 유통에 필요한 인프라는 복잡하고, 특히 저자원 환경에서는 비용이 많이 듭니다. 따라서 물류 측면에서 장애물이 높고 도입이 지연되거나 비용이 증가할 수 있습니다. 마지막으로, 병원체의 급속한 진화는 백신 제형의 지속적인 갱신을 필요로 하고, 지속적인 투자와 적응을 필요로 합니다. 이러한 요인은 DNA 백신 시장의 성장과 확장성을 위협하는 것으로, 이들을 극복하는 전략적 솔루션이 필요합니다.

주요 기업

Inovio Pharmaceuticals, GeneOne Life Science, VGXI, Aldevron, Zydus Cadila, CureVac, AnGes, BioNTech, Genexine, Takis Biotech, Vaxine Pty Ltd, Immunomic Therapeutics, OncoSec Medical, CEL-SCI Corporation, Vical

목차

제1장 DNA 백신 시장 개요

  • 조사 목적
  • DNA 백신 시장 정의와 조사 범위
  • 보고서의 제한 사항
  • 조사 대상 연도 및 통화
  • 조사 방법

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 DNA 백신 시장 전망

  • DNA 백신 시장 세분화
  • 시장 역학
  • Porter's Five Forces 분석
  • PESTLE 분석
  • 밸류체인 분석
  • 4P 모델
  • ANSOFF 매트릭스

제5장 DNA 백신 시장 전략

  • 상위 시장 분석
  • 수급 분석
  • 소비자의 구매 의욕
  • 사례 연구 분석
  • 가격 분석
  • 규제 상황
  • 공급망 분석
  • 경쟁 제품 분석
  • 최근 동향

제6장 DNA 백신 시장 규모

  • DNA 백신 시장 규모 : 금액별
  • DNA 백신 시장 규모 : 수량별

제7장 DNA 백신 시장 : 유형별

  • 시장 개요
  • 예방용 DNA 백신
  • 치료용 DNA 백신
  • 기타

제8장 DNA 백신 시장 : 제품별

  • 시장 개요
  • 세균 DNA 백신
  • 바이러스 DNA 백신
  • 암 DNA 백신
  • 기타

제9장 DNA 백신 시장 : 기술별

  • 시장 개요
  • 일렉트로포레이션에 의한 전달
  • 유전자총 배달
  • 리포솜 기반 전달
  • 나노 파티클 기반 전달
  • 기타

제10장 DNA 백신 시장 : 용도별

  • 시장 개요
  • 감염증
  • 알레르기 질환
  • 자가면역질환
  • 기타

제11장 DNA 백신 시장 : 최종 사용자별

  • 시장 개요
  • 병원
  • 연구기관
  • 바이오 제약 회사
  • 기타

제12장 DNA 백신 시장 : 프로세스별

  • 시장 개요
  • In Vivo 생산
  • Ex Vivo 생산
  • 기타

제13장 DNA 백신 시장 : 기능별

  • 시장 개요
  • 유전자 발현
  • 항원 제시
  • 면역 반응 활성화
  • 기타

제14장 DNA 백신 시장 : 설치 유형별

  • 시장 개요
  • 독립형 시스템
  • 통합형 시스템
  • 기타

제15장 DNA 백신 시장 : 솔루션별

  • 시장 개요
  • 커스텀 DNA 백신 개발
  • 전임상시험 서비스
  • 임상시험 서비스
  • 기타

제16장 DNA 백신 시장 : 지역별

  • 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 네덜란드
    • 스웨덴
    • 스위스
    • 덴마크
    • 핀란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 싱가포르
    • 인도네시아
    • 대만
    • 말레이시아
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카
    • 기타 중동 및 아프리카

제17장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 주요 기업의 포지셔닝
  • 경쟁 리더십 매핑
  • 벤더 벤치마킹
  • 개발 전략의 벤치마킹

제18장 기업 프로파일

  • Inovio Pharmaceuticals
  • GeneOne Life Science
  • VGXI
  • Aldevron
  • Zydus Cadila
  • CureVac
  • AnGes
  • BioNTech
  • Genexine
  • Takis Biotech
  • Vaxine Pty Ltd
  • Immunomic Therapeutics
  • OncoSec Medical
  • CEL-SCI Corporation
  • Vical
JHS 25.10.20

DNA Vaccine Market is anticipated to expand from $850.7 million in 2024 to $1574.6 million by 2034, growing at a CAGR of approximately 6.4%. The DNA Vaccine Market encompasses vaccines that use engineered DNA to elicit an immune response against diseases. These vaccines offer stability, ease of production, and rapid development potential, particularly against emerging infectious diseases and cancer. The market is driven by technological advancements, increasing R&D investments, and the need for novel vaccine solutions. Regulatory support and strategic collaborations further accelerate market growth, positioning DNA vaccines as a transformative force in preventive medicine.

The DNA Vaccine Market is expanding rapidly, propelled by advancements in genetic engineering and immunology. The human vaccine segment leads in performance, driven by the increasing prevalence of infectious diseases and cancer. Within this, the therapeutic vaccine sub-segment shows significant promise, particularly in oncology applications. The veterinary vaccine segment is the second highest performer, with livestock vaccines gaining traction due to rising concerns over zoonotic diseases. DNA vaccines for aquaculture also present lucrative opportunities, addressing the need for sustainable fish farming practices. The growing acceptance of DNA vaccines is further fueled by their ability to induce robust immune responses and their potential for rapid development. Technological innovations, such as electroporation and nanoparticle delivery systems, enhance vaccine efficacy and patient compliance. Strategic partnerships and collaborations among biotech firms and research institutions are accelerating product development. Regulatory support and favorable government policies are anticipated to sustain market growth, positioning DNA vaccines as a transformative force in modern medicine.

Market Segmentation
TypeProphylactic DNA Vaccines, Therapeutic DNA Vaccines
ProductBacterial DNA Vaccines, Viral DNA Vaccines, Cancer DNA Vaccines
TechnologyElectroporation-enhanced Delivery, Gene Gun Delivery, Liposome-based Delivery, Nanoparticle-based Delivery
ApplicationInfectious Diseases, Cancer, Allergic Diseases, Autoimmune Diseases
End UserHospitals, Research Institutes, Biopharmaceutical Companies
ProcessIn Vivo Production, Ex Vivo Production
FunctionalityGene Expression, Antigen Presentation, Immune Response Activation
Installation TypeStandalone Systems, Integrated Systems
SolutionsCustom DNA Vaccine Development, Preclinical Testing Services, Clinical Trial Services

Market Snapshot:

The DNA vaccine market is experiencing dynamic shifts in market share, pricing, and product innovation. Key players are continually launching new products to meet the rising demand for effective and safe vaccines. The competitive landscape is characterized by strategic pricing models and innovative solutions that cater to diverse consumer needs. This evolution is driven by advancements in biotechnology and increasing awareness of DNA vaccines' potential benefits. Companies are leveraging these trends to capture significant market shares, with North America and Europe leading the charge in product launches and technological innovations. Competition benchmarking reveals a highly competitive environment with major pharmaceutical companies at the forefront. Regulatory influences, particularly in North America and Europe, are pivotal in shaping market dynamics. These regulations ensure safety and efficacy, thus impacting market entry and growth strategies. The market is marked by intense R&D activities, with a focus on developing vaccines for a range of infectious diseases. Emerging markets in Asia-Pacific and Latin America present lucrative opportunities, driven by increasing healthcare investments and favorable government policies.

Geographical Overview:

The DNA vaccine market is witnessing notable growth across different regions, each characterized by unique opportunities. North America stands at the forefront, propelled by robust research initiatives and a supportive regulatory environment. The presence of key industry players and substantial funding for vaccine development further enhances its market leadership. Europe follows, with strong governmental support and a focus on innovative healthcare solutions driving market expansion. The region's commitment to advancing biotechnology and personalized medicine strengthens its position. In Asia Pacific, the market is rapidly expanding due to increasing healthcare investments and rising awareness of vaccine benefits. Countries like China and India are emerging as significant contributors, with their growing biotechnology sectors and government-backed initiatives. Latin America and the Middle East & Africa present promising growth pockets. In Latin America, a burgeoning interest in biotechnology and improving healthcare infrastructure are fostering market growth. Meanwhile, the Middle East & Africa are recognizing the potential of DNA vaccines in addressing regional health challenges and are investing in relevant technologies.

Key Trends and Drivers:

The DNA vaccine market is experiencing robust growth, driven by technological advancements and increased investment in biotechnology. Key trends include the rising prevalence of infectious diseases and the urgent need for rapid vaccine development. This has accelerated research and development efforts in DNA vaccines, which offer a faster and more adaptable response compared to traditional vaccines. Regulatory frameworks are evolving to accommodate the unique characteristics of DNA vaccines, facilitating smoother approval processes. The demand for personalized medicine is also propelling the market, as DNA vaccines can be tailored to individual genetic profiles. Additionally, the increasing use of DNA vaccines in veterinary medicine is expanding the market's scope. Strategic partnerships between pharmaceutical companies and research institutions are fostering innovation and enhancing the pipeline of DNA vaccines. Opportunities abound in emerging markets where healthcare infrastructure is improving, and there is a growing focus on preventive healthcare measures. The DNA vaccine market is poised for significant expansion, driven by these compelling trends and drivers.

Restraints and Challenges:

The DNA vaccine market encounters several significant restraints and challenges. Stringent regulatory requirements pose a formidable barrier, as they necessitate extensive safety and efficacy evaluations, prolonging the time to market. This can deter investment and slow innovation. Moreover, the high cost of research and development in the biotechnology sector limits participation to well-funded entities, potentially stifling competition and diversity. Public skepticism and misinformation surrounding genetic technologies further complicate market acceptance. Many consumers harbor concerns about genetic manipulation, which can impede widespread adoption. Additionally, the infrastructure required for manufacturing and distribution of DNA vaccines is complex and costly, particularly in low-resource settings. This presents logistical hurdles that can delay deployment and increase expenses. Lastly, the rapid evolution of pathogens necessitates continual updates to vaccine formulations, requiring ongoing investment and adaptation. These factors collectively challenge the growth and scalability of the DNA vaccine market, necessitating strategic solutions to overcome them.

Key Players:

Inovio Pharmaceuticals, GeneOne Life Science, VGXI, Aldevron, Zydus Cadila, CureVac, AnGes, BioNTech, Genexine, Takis Biotech, Vaxine Pty Ltd, Immunomic Therapeutics, OncoSec Medical, CEL-SCI Corporation, Vical

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: DNA Vaccine Market Overview

  • 1.1 Objectives of the Study
  • 1.2 DNA Vaccine Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Technology
  • 2.6 Key Highlights of the Market, by Application
  • 2.7 Key Highlights of the Market, by End User
  • 2.8 Key Highlights of the Market, by Process
  • 2.9 Key Highlights of the Market, by Functionality
  • 2.10 Key Highlights of the Market, by Installation Type
  • 2.11 Key Highlights of the Market, by Solutions
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Technology
  • 3.5 Market Attractiveness Analysis, by Application
  • 3.6 Market Attractiveness Analysis, by End User
  • 3.7 Market Attractiveness Analysis, by Process
  • 3.8 Market Attractiveness Analysis, by Functionality
  • 3.9 Market Attractiveness Analysis, by Installation Type
  • 3.10 Market Attractiveness Analysis, by Solutions
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: DNA Vaccine Market Outlook

  • 4.1 DNA Vaccine Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: DNA Vaccine Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: DNA Vaccine Market Size

  • 6.1 DNA Vaccine Market Size, by Value
  • 6.2 DNA Vaccine Market Size, by Volume

7: DNA Vaccine Market, by Type

  • 7.1 Market Overview
  • 7.2 Prophylactic DNA Vaccines
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Therapeutic DNA Vaccines
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Others
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region

8: DNA Vaccine Market, by Product

  • 8.1 Market Overview
  • 8.2 Bacterial DNA Vaccines
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Viral DNA Vaccines
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Cancer DNA Vaccines
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Others
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region

9: DNA Vaccine Market, by Technology

  • 9.1 Market Overview
  • 9.2 Electroporation-enhanced Delivery
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Gene Gun Delivery
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Liposome-based Delivery
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Nanoparticle-based Delivery
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Others
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region

10: DNA Vaccine Market, by Application

  • 10.1 Market Overview
  • 10.2 Infectious Diseases
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Cancer
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Allergic Diseases
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Autoimmune Diseases
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Others
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region

11: DNA Vaccine Market, by End User

  • 11.1 Market Overview
  • 11.2 Hospitals
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Research Institutes
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Biopharmaceutical Companies
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Others
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region

12: DNA Vaccine Market, by Process

  • 12.1 Market Overview
  • 12.2 In Vivo Production
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Ex Vivo Production
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Others
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region

13: DNA Vaccine Market, by Functionality

  • 13.1 Market Overview
  • 13.2 Gene Expression
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Antigen Presentation
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Immune Response Activation
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Others
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region

14: DNA Vaccine Market, by Installation Type

  • 14.1 Market Overview
  • 14.2 Standalone Systems
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Integrated Systems
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Others
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region

15: DNA Vaccine Market, by Solutions

  • 15.1 Market Overview
  • 15.2 Custom DNA Vaccine Development
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Preclinical Testing Services
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Clinical Trial Services
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: DNA Vaccine Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Technology
    • 16.2.5 North America Market Size and Forecast, by Application
    • 16.2.6 North America Market Size and Forecast, by End User
    • 16.2.7 North America Market Size and Forecast, by Process
    • 16.2.8 North America Market Size and Forecast, by Functionality
    • 16.2.9 North America Market Size and Forecast, by Installation Type
    • 16.2.10 North America Market Size and Forecast, by Solutions
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Technology
      • 16.2.9.4 United States Market Size and Forecast, by Application
      • 16.2.9.5 United States Market Size and Forecast, by End User
      • 16.2.9.6 United States Market Size and Forecast, by Process
      • 16.2.9.7 United States Market Size and Forecast, by Functionality
      • 16.2.9.8 United States Market Size and Forecast, by Installation Type
      • 16.2.9.9 United States Market Size and Forecast, by Solutions
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Technology
      • 16.2.10.4 Canada Market Size and Forecast, by Application
      • 16.2.10.5 Canada Market Size and Forecast, by End User
      • 16.2.10.6 Canada Market Size and Forecast, by Process
      • 16.2.10.7 Canada Market Size and Forecast, by Functionality
      • 16.2.10.8 Canada Market Size and Forecast, by Installation Type
      • 16.2.10.9 Canada Market Size and Forecast, by Solutions
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Technology
    • 16.3.5 Europe Market Size and Forecast, by Application
    • 16.3.6 Europe Market Size and Forecast, by End User
    • 16.3.7 Europe Market Size and Forecast, by Process
    • 16.3.8 Europe Market Size and Forecast, by Functionality
    • 16.3.9 Europe Market Size and Forecast, by Installation Type
    • 16.3.10 Europe Market Size and Forecast, by Solutions
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.5 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.6 United Kingdom Market Size and Forecast, by Process
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Functionality
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Installation Type
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Solutions
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Technology
      • 16.3.10.4 Germany Market Size and Forecast, by Application
      • 16.3.10.5 Germany Market Size and Forecast, by End User
      • 16.3.10.6 Germany Market Size and Forecast, by Process
      • 16.3.10.7 Germany Market Size and Forecast, by Functionality
      • 16.3.10.8 Germany Market Size and Forecast, by Installation Type
      • 16.3.10.9 Germany Market Size and Forecast, by Solutions
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Technology
      • 16.3.11.4 France Market Size and Forecast, by Application
      • 16.3.11.5 France Market Size and Forecast, by End User
      • 16.3.11.6 France Market Size and Forecast, by Process
      • 16.3.11.7 France Market Size and Forecast, by Functionality
      • 16.3.11.8 France Market Size and Forecast, by Installation Type
      • 16.3.11.9 France Market Size and Forecast, by Solutions
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Technology
      • 16.3.12.4 Spain Market Size and Forecast, by Application
      • 16.3.12.5 Spain Market Size and Forecast, by End User
      • 16.3.12.6 Spain Market Size and Forecast, by Process
      • 16.3.12.7 Spain Market Size and Forecast, by Functionality
      • 16.3.12.8 Spain Market Size and Forecast, by Installation Type
      • 16.3.12.9 Spain Market Size and Forecast, by Solutions
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Technology
      • 16.3.13.4 Italy Market Size and Forecast, by Application
      • 16.3.13.5 Italy Market Size and Forecast, by End User
      • 16.3.13.6 Italy Market Size and Forecast, by Process
      • 16.3.13.7 Italy Market Size and Forecast, by Functionality
      • 16.3.13.8 Italy Market Size and Forecast, by Installation Type
      • 16.3.13.9 Italy Market Size and Forecast, by Solutions
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.4 Netherlands Market Size and Forecast, by Application
      • 16.3.14.5 Netherlands Market Size and Forecast, by End User
      • 16.3.14.6 Netherlands Market Size and Forecast, by Process
      • 16.3.14.7 Netherlands Market Size and Forecast, by Functionality
      • 16.3.14.8 Netherlands Market Size and Forecast, by Installation Type
      • 16.3.14.9 Netherlands Market Size and Forecast, by Solutions
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Technology
      • 16.3.15.4 Sweden Market Size and Forecast, by Application
      • 16.3.15.5 Sweden Market Size and Forecast, by End User
      • 16.3.15.6 Sweden Market Size and Forecast, by Process
      • 16.3.15.7 Sweden Market Size and Forecast, by Functionality
      • 16.3.15.8 Sweden Market Size and Forecast, by Installation Type
      • 16.3.15.9 Sweden Market Size and Forecast, by Solutions
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.4 Switzerland Market Size and Forecast, by Application
      • 16.3.16.5 Switzerland Market Size and Forecast, by End User
      • 16.3.16.6 Switzerland Market Size and Forecast, by Process
      • 16.3.16.7 Switzerland Market Size and Forecast, by Functionality
      • 16.3.16.8 Switzerland Market Size and Forecast, by Installation Type
      • 16.3.16.9 Switzerland Market Size and Forecast, by Solutions
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Technology
      • 16.3.17.4 Denmark Market Size and Forecast, by Application
      • 16.3.17.5 Denmark Market Size and Forecast, by End User
      • 16.3.17.6 Denmark Market Size and Forecast, by Process
      • 16.3.17.7 Denmark Market Size and Forecast, by Functionality
      • 16.3.17.8 Denmark Market Size and Forecast, by Installation Type
      • 16.3.17.9 Denmark Market Size and Forecast, by Solutions
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Technology
      • 16.3.18.4 Finland Market Size and Forecast, by Application
      • 16.3.18.5 Finland Market Size and Forecast, by End User
      • 16.3.18.6 Finland Market Size and Forecast, by Process
      • 16.3.18.7 Finland Market Size and Forecast, by Functionality
      • 16.3.18.8 Finland Market Size and Forecast, by Installation Type
      • 16.3.18.9 Finland Market Size and Forecast, by Solutions
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Technology
      • 16.3.19.4 Russia Market Size and Forecast, by Application
      • 16.3.19.5 Russia Market Size and Forecast, by End User
      • 16.3.19.6 Russia Market Size and Forecast, by Process
      • 16.3.19.7 Russia Market Size and Forecast, by Functionality
      • 16.3.19.8 Russia Market Size and Forecast, by Installation Type
      • 16.3.19.9 Russia Market Size and Forecast, by Solutions
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by Process
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Functionality
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Installation Type
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Solutions
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.6 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.7 Asia-Pacific Market Size and Forecast, by Process
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Functionality
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Installation Type
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Solutions
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Technology
      • 16.4.9.4 China Market Size and Forecast, by Application
      • 16.4.9.5 China Market Size and Forecast, by End User
      • 16.4.9.6 China Market Size and Forecast, by Process
      • 16.4.9.7 China Market Size and Forecast, by Functionality
      • 16.4.9.8 China Market Size and Forecast, by Installation Type
      • 16.4.9.9 China Market Size and Forecast, by Solutions
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Technology
      • 16.4.10.4 India Market Size and Forecast, by Application
      • 16.4.10.5 India Market Size and Forecast, by End User
      • 16.4.10.6 India Market Size and Forecast, by Process
      • 16.4.10.7 India Market Size and Forecast, by Functionality
      • 16.4.10.8 India Market Size and Forecast, by Installation Type
      • 16.4.10.9 India Market Size and Forecast, by Solutions
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Technology
      • 16.4.11.4 Japan Market Size and Forecast, by Application
      • 16.4.11.5 Japan Market Size and Forecast, by End User
      • 16.4.11.6 Japan Market Size and Forecast, by Process
      • 16.4.11.7 Japan Market Size and Forecast, by Functionality
      • 16.4.11.8 Japan Market Size and Forecast, by Installation Type
      • 16.4.11.9 Japan Market Size and Forecast, by Solutions
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Technology
      • 16.4.12.4 South Korea Market Size and Forecast, by Application
      • 16.4.12.5 South Korea Market Size and Forecast, by End User
      • 16.4.12.6 South Korea Market Size and Forecast, by Process
      • 16.4.12.7 South Korea Market Size and Forecast, by Functionality
      • 16.4.12.8 South Korea Market Size and Forecast, by Installation Type
      • 16.4.12.9 South Korea Market Size and Forecast, by Solutions
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Technology
      • 16.4.13.4 Australia Market Size and Forecast, by Application
      • 16.4.13.5 Australia Market Size and Forecast, by End User
      • 16.4.13.6 Australia Market Size and Forecast, by Process
      • 16.4.13.7 Australia Market Size and Forecast, by Functionality
      • 16.4.13.8 Australia Market Size and Forecast, by Installation Type
      • 16.4.13.9 Australia Market Size and Forecast, by Solutions
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Technology
      • 16.4.14.4 Singapore Market Size and Forecast, by Application
      • 16.4.14.5 Singapore Market Size and Forecast, by End User
      • 16.4.14.6 Singapore Market Size and Forecast, by Process
      • 16.4.14.7 Singapore Market Size and Forecast, by Functionality
      • 16.4.14.8 Singapore Market Size and Forecast, by Installation Type
      • 16.4.14.9 Singapore Market Size and Forecast, by Solutions
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.4 Indonesia Market Size and Forecast, by Application
      • 16.4.15.5 Indonesia Market Size and Forecast, by End User
      • 16.4.15.6 Indonesia Market Size and Forecast, by Process
      • 16.4.15.7 Indonesia Market Size and Forecast, by Functionality
      • 16.4.15.8 Indonesia Market Size and Forecast, by Installation Type
      • 16.4.15.9 Indonesia Market Size and Forecast, by Solutions
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.4 Taiwan Market Size and Forecast, by Application
      • 16.4.16.5 Taiwan Market Size and Forecast, by End User
      • 16.4.16.6 Taiwan Market Size and Forecast, by Process
      • 16.4.16.7 Taiwan Market Size and Forecast, by Functionality
      • 16.4.16.8 Taiwan Market Size and Forecast, by Installation Type
      • 16.4.16.9 Taiwan Market Size and Forecast, by Solutions
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.4 Malaysia Market Size and Forecast, by Application
      • 16.4.17.5 Malaysia Market Size and Forecast, by End User
      • 16.4.17.6 Malaysia Market Size and Forecast, by Process
      • 16.4.17.7 Malaysia Market Size and Forecast, by Functionality
      • 16.4.17.8 Malaysia Market Size and Forecast, by Installation Type
      • 16.4.17.9 Malaysia Market Size and Forecast, by Solutions
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Functionality
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Installation Type
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Solutions
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Technology
    • 16.5.5 Latin America Market Size and Forecast, by Application
    • 16.5.6 Latin America Market Size and Forecast, by End User
    • 16.5.7 Latin America Market Size and Forecast, by Process
    • 16.5.8 Latin America Market Size and Forecast, by Functionality
    • 16.5.9 Latin America Market Size and Forecast, by Installation Type
    • 16.5.10 Latin America Market Size and Forecast, by Solutions
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Technology
      • 16.5.9.4 Brazil Market Size and Forecast, by Application
      • 16.5.9.5 Brazil Market Size and Forecast, by End User
      • 16.5.9.6 Brazil Market Size and Forecast, by Process
      • 16.5.9.7 Brazil Market Size and Forecast, by Functionality
      • 16.5.9.8 Brazil Market Size and Forecast, by Installation Type
      • 16.5.9.9 Brazil Market Size and Forecast, by Solutions
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Technology
      • 16.5.10.4 Mexico Market Size and Forecast, by Application
      • 16.5.10.5 Mexico Market Size and Forecast, by End User
      • 16.5.10.6 Mexico Market Size and Forecast, by Process
      • 16.5.10.7 Mexico Market Size and Forecast, by Functionality
      • 16.5.10.8 Mexico Market Size and Forecast, by Installation Type
      • 16.5.10.9 Mexico Market Size and Forecast, by Solutions
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Technology
      • 16.5.11.4 Argentina Market Size and Forecast, by Application
      • 16.5.11.5 Argentina Market Size and Forecast, by End User
      • 16.5.11.6 Argentina Market Size and Forecast, by Process
      • 16.5.11.7 Argentina Market Size and Forecast, by Functionality
      • 16.5.11.8 Argentina Market Size and Forecast, by Installation Type
      • 16.5.11.9 Argentina Market Size and Forecast, by Solutions
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by Process
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Functionality
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Installation Type
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Solutions
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.6 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.7 Middle East and Africa Market Size and Forecast, by Process
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Functionality
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Installation Type
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Solutions
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by Process
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Functionality
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Installation Type
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Solutions
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Technology
      • 16.6.10.4 UAE Market Size and Forecast, by Application
      • 16.6.10.5 UAE Market Size and Forecast, by End User
      • 16.6.10.6 UAE Market Size and Forecast, by Process
      • 16.6.10.7 UAE Market Size and Forecast, by Functionality
      • 16.6.10.8 UAE Market Size and Forecast, by Installation Type
      • 16.6.10.9 UAE Market Size and Forecast, by Solutions
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Technology
      • 16.6.11.4 South Africa Market Size and Forecast, by Application
      • 16.6.11.5 South Africa Market Size and Forecast, by End User
      • 16.6.11.6 South Africa Market Size and Forecast, by Process
      • 16.6.11.7 South Africa Market Size and Forecast, by Functionality
      • 16.6.11.8 South Africa Market Size and Forecast, by Installation Type
      • 16.6.11.9 South Africa Market Size and Forecast, by Solutions
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by Process
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Functionality
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Installation Type
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Solutions
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 Inovio Pharmaceuticals
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 GeneOne Life Science
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 VGXI
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 Aldevron
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Zydus Cadila
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 CureVac
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 AnGes
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 BioNTech
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Genexine
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 Takis Biotech
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Vaxine Pty Ltd
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Immunomic Therapeutics
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 OncoSec Medical
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 CEL-SCI Corporation
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 Vical
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제